Prot# CZOL446M2308: Randomized, Multicenter, Double-Blind, Double-Dummy, Parallel Group Study to Determine the Efficacy & Safety of Intravenous Zoledronic Acid 5mg Annually Compared to Oral Alendronate 70mg Weekly for the Treatment of Osteoporosis in Men

Project: Research project

Project Details

StatusFinished
Effective start/end date7/2/04 → 6/20/08

Funding

  • Parexel (CZOL446M2308)
  • Novartis Pharmaceuticals Corporation (CZOL446M2308)